Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study
1 other identifier
observational
20
1 country
1
Brief Summary
Despite large efforts trying to improve diagnostic and therapy of sepsis have been made over the last decade (e.g. initiation of the Surviving Sepsis Campaign, defining evidence based sepsis therapy bundles) the mortality of septic shock remains high and causes high socioeconomical burden of disease. The purpose of this pilot study is to evaluate the design and conduct of a projected full scale clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2014
CompletedFirst Posted
Study publicly available on registry
January 24, 2014
CompletedStudy Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2019
CompletedJune 16, 2020
June 1, 2020
3.8 years
January 20, 2014
June 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of circadian regulation
Circadian regulation by expression of clock genes
These parameters are measured during intensive care unit stay, for a maximum of 3 days
Secondary Outcomes (14)
Time on mechanical ventilation
They are followed up until the end of intensive care unit stay - or, for a maximum of 28 days
Intensive care unit length of stay
Participants will be followed for the duration of intensive care stay, an expected average of 4 weeks
Hospital length of stay
Participants will be followed for the duration of intensive care stay, an expected average of 5 weeks
Simplified Acute Physiology Score (SOFA II)
They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.
Sequential Organ Failure Assessment (SOFA)
They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.
- +9 more secondary outcomes
Other Outcomes (2)
Nagalase enzyme activity
This parameter is measured at the beginning of the investigation
Venous return
This parameter is measured at the beginning of the investigation
Study Arms (1)
Critically ill patients
Intensive care unit patients with refractory septic shock
Eligibility Criteria
Critically ill patients with septic shock
You may qualify if:
- Male and female patients with age 18 years and above,
- Patient at intensive care units (8i, 9i and 1i at Charité - University Medicine Berlin , Campus Virchow- Klinikum),
- Septic shock (ACCP/SCCM (American College of Chest Physicians/Society of Critical Care Medicine) consensus definitions) AND Norepinephrine dosage of \>0.3 μg/kg/min for at least 2 hours
You may not qualify if:
- Pregnant or lactating female patient,
- Acute leucemia,
- Severe leukocytosis (\>50,000/nl),
- Severe thrombocytopenia (\<5,000/nl),
- Autoimmune disease with systemic medication of ≥10 mg prednisolone equivalent or previous transplantation,
- Patients receiving interferon therapy (last 14 days),
- Patients with known hypersensitivity GM-CSF or known antibodies against GM-CSF, yeast-derived products or any component of the study medication,
- Ongoing (concomitant) chemotherapy or radiotherapy for malignancy,
- Acute pulmonary embolism or acute myocardial infarction within last 72 hours,
- Cardiopulmonary resuscitation within last 7 days,
- Moribund patient (life expectancy \<72 hrs.),
- Presence of a do-not-resuscitate or do-not-intubate order,
- Known human immunodeficiency virus (HIV) infection or chronic viral hepatitis
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Claudia Spieslead
Study Sites (1)
Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow - Klinikum, Charité- Universitätsmedizin
Berlin, 13353, Germany
Related Publications (3)
Bellet MM, Deriu E, Liu JZ, Grimaldi B, Blaschitz C, Zeller M, Edwards RA, Sahar S, Dandekar S, Baldi P, George MD, Raffatellu M, Sassone-Corsi P. Circadian clock regulates the host response to Salmonella. Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9897-902. doi: 10.1073/pnas.1120636110. Epub 2013 May 28.
PMID: 23716692BACKGROUNDLim AS, Chang AM, Shulman JM, Raj T, Chibnik LB, Cain SW, Rothamel K, Benoist C, Myers AJ, Czeisler CA, Buchman AS, Bennett DA, Duffy JF, Saper CB, De Jager PL. A common polymorphism near PER1 and the timing of human behavioral rhythms. Ann Neurol. 2012 Sep;72(3):324-34. doi: 10.1002/ana.23636.
PMID: 23034908BACKGROUNDLachmann G, Ananthasubramaniam B, Wunsch VA, Scherfig LM, von Haefen C, Knaak C, Edel A, Ehlen L, Koller B, Goldmann A, Herzel H, Kramer A, Spies C. Circadian rhythms in septic shock patients. Ann Intensive Care. 2021 Apr 26;11(1):64. doi: 10.1186/s13613-021-00833-5.
PMID: 33900485DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Claudia Spies, MD, Prof.
Charite University, Berlin, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Department of Anesthesiology and Intensive Care Medicine, CVK/CCM, Charité - University Medicine Berlin
Study Record Dates
First Submitted
January 20, 2014
First Posted
January 24, 2014
Study Start
April 1, 2014
Primary Completion
January 21, 2018
Study Completion
March 31, 2019
Last Updated
June 16, 2020
Record last verified: 2020-06